Search

everythinglearnresearchcommunity

for

Search:↓

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Both botulinum toxin A and multivitamin mesotherapy effectively treat hair loss, with botulinum toxin A being the better single-session option.

COVID-19 has increased hair loss, but many patients see regrowth within months.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Hair transplant surgery can cause temporary hair loss in the area where hair was taken from.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

The drug Albendazole, used for treating parasites, can cause sudden hair loss.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Higher Vitamin-D levels may help treat certain types of hair loss.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

Iron deficiency is more common in women with excessive hair loss.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

The debate focuses on the role of catagen and hair shedding mechanisms in telogen effluvium.

Hair loss might be an early sign of Hodgkin disease.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

Hair loss occurred after a COVID-19 infection.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Post-COVID-19 hair loss is likely due to stress and inflammation.